Aevi Genomic Medicine Inc (GNMX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Michael F. Cola
Employees:
14
435 DEVON PARK DRIVE,, SUITE 715, WAYNE, PA, 19087
610-254-4201
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Aevi Genomic Medicine, Inc. is a medical technology company, which focuses on finding treatments for rare and orphan diseases, with a particular focus on pediatrics, following a genomics medicine strategy. Its Transduced Autologous Restorative Gene Therapy platform is designed to provide sustained protein and peptide therapies to treat a range of chronic diseases and conditions. The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|